Log in to save to my catalogue

Measuring Overall Severity of Myasthenia Gravis (MG): Evidence for the Added Value of the MG Symptom...

Measuring Overall Severity of Myasthenia Gravis (MG): Evidence for the Added Value of the MG Symptom...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_131a281df393491aae95d0337bb8b940

Measuring Overall Severity of Myasthenia Gravis (MG): Evidence for the Added Value of the MG Symptoms PRO

About this item

Full title

Measuring Overall Severity of Myasthenia Gravis (MG): Evidence for the Added Value of the MG Symptoms PRO

Publisher

Cheshire: Springer Healthcare

Journal title

Neurology and Therapy, 2023-10, Vol.12 (5), p.1573-1590

Language

English

Formats

Publication information

Publisher

Cheshire: Springer Healthcare

More information

Scope and Contents

Contents

Introduction
Accurate measurement of myasthenia gravis (MG) severity is required for appropriate clinical monitoring of patients with MG and assessment of the benefit of new treatments in clinical trials. Our objective was to explore how MG severity can be measured and to determine how the newly developed MG Symptoms Patient-Reported Outcome (PR...

Alternative Titles

Full title

Measuring Overall Severity of Myasthenia Gravis (MG): Evidence for the Added Value of the MG Symptoms PRO

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_131a281df393491aae95d0337bb8b940

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_131a281df393491aae95d0337bb8b940

Other Identifiers

ISSN

2193-8253

E-ISSN

2193-6536

DOI

10.1007/s40120-023-00464-x

How to access this item